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Aims: Evaluating myocardial infarct (MI) size prior to intervention is fundamental to ensure accurate results
in experimental studies. However, this assessment is performed at late time points. We aimed to evaluate
whether measuring plasma cardiac troponin I (cTnI) and performing echocardiographic assessment at earlier
time points can predict the occurrence of MI and infarct size.
Main methods: Male Wistar rats were subjected to MI (n = 40) or sham surgery (n = 11). cTnI levels were
measured 2 and 8 h after MI. Echocardiographic evaluations were performed at 48 h and 14 days post-MI.
After 14 days, the animals were euthanized, and the hearts were removed and parafﬁn-embedded for Sirius
red staining.
Key ﬁndings: cTnI plasma levels increased in theMI group relative to the shamgroup at 2 h afterMI (7.2 ± 9.4 ng/
mLvs. 2.3 ± 1.0 ng/mL; p b 0.01)with a further increase at 8 h afterMI (22.2 ± 13.5 ng/mLvs. 1.5 ± 1.7 ng/mL;
p b 0.001). cTnI levels (8 h) and echocardiographic outcomes correlatedwith histological infarct size 14 days after
MI (r = 0.74, p b 0.001 and r = 0.84, p b 0.001, respectively), but only echocardiography could conﬁdently iden-
tify small, medium, and large infarcts. Additionally, using a cutoff value of 4.8 ng/mL we achieved 100% speciﬁcity
and 91% sensitivity in detecting MI.
Signiﬁcance: A cutoff value of 4.8 ng/mL for cTnI could be used as early as 8 h after MI to accurately identify
infarct in this model, whereas echocardiographic images taken 48 h after MI predicted the infarcted area
14 days after MI.© 2013 Elsevier Inc. All rights reserved.Introduction
Transmural myocardial infarction (MI) is a pivotal event that trig-
gers adverse ventricular remodeling, including cardiomyocyte loss,
extracellular matrix deposition and ﬁbroblast growth (Pfeffer and
Braunwald, 1990; Vilahur et al., 2011). This remodeling process may
lead to ventricular dysfunction and eventually to congestive heart
failure (Pfeffer and Braunwald, 1990).
Currently, the most common preclinical method to induce heart
failure is performed either in rats or mice via the ligation of the left
anterior descending coronary artery (Pfeffer et al., 1979; Zaragoza et
al., 2011). Despite being widely used, a limitation concerning the var-
iability of the resultant infarct sizes, ranging from 8 to 65%, has been
noted (Degabriele et al., 2004). Because infarct size is a major deter-
minant of ventricular remodeling, it must be carefully estimatedorto Alegre, RS, CEP 90035-903,
.
ually to this work.
rights reserved.before introducing a potential intervention in order to avoid attribut-
ing to the intervention any effect that may be related to the intrinsic
variability of the model.
Histological analysis is widely employed as a reference method to
evaluate infarct size in experimental studies (Stegger et al., 2006;
Wollenweber et al., 2010). However, it is necessarily performed at
the end of the experimental protocol. Less invasive approaches to
evaluate infarct area include plasma injury markers and echocardio-
graphic imaging. Both have been used to predict ﬁnal ventricular re-
modeling parameters and are usually employed after several hours
of delay in relation to the MI. Cardiac troponin T levels, collected
24 h after MI, are described as good predictors of heart failure devel-
opment in rats (Jiang et al., 2011). Additionally, an echocardiographic
analysis at 5 days after MI adequately predicts cardiac remodeling
after 3 months (Minicucci et al., 2011). However, an early evaluation
of MI size and its relation to the histological assessment of MI exten-
sion in rat model remains unexplored. Therefore, the purpose of the
present study was to characterize cardiac troponin I (cTnI) measured
8 h after MI and echocardiographic parameters assessed 48 h after MI
as tools to diagnose MI and estimate MI size at 14 days post-MI.
140 G.G. Vietta et al. / Life Sciences 93 (2013) 139–144Methods
Ethical approval
This studywas approved by the institutional ethics committee (Hos-
pital de Clínicas de Porto Alegre) and performed in accordance with
Brazilian and international guidelines for animal experimentation
(Guide for the Care and Use of Laboratory Animals, Association for As-
sessment and Accreditation of Laboratory Animal Care International).
Animals
A total of 51 rats (male Wistar, 8 week-old) were subjected to MI
(n = 40) or sham surgery (n = 11), as described below. A schematic
timeline of the experimental design can be observed in Fig. 1. It is note-
worthy that not all of the data were collected for each animal due to
technical issues, mainly related to an image acquisition limitation.
Thus, the correct sample number for each analysis is presented in the
respective ﬁgure or table legend. All of the animals were maintained
on a 12-hour light–dark cycle and received water and food ad libitum.
Myocardial infarction and sham procedures
Myocardial infarction was induced according to a procedure previ-
ously described in the literature and adapted in our laboratory
(Tavares et al., 2010). Brieﬂy, the animals were placed in the dorsal
decubitus position and anesthetized with ketamine (100 mg/kg)
and xylazine (10 mg/kg) administered intraperitoneally. Following
orotracheal intubation, the animals were submitted to mechanical ven-
tilation with a Harvard ventilator, Model 683 (Harvard Apparatus,
Holliston, MA, USA) (frequency: 75–80 breaths/min, tidal volume:
2.0 mL) with O2 supplementation and maintained on a 37 °C hot
plate. Subsequently, a surgical incision was made in the skin along the
left sternal margin, and divulsion of the pectoralis and transverse mus-
cles was performed. Thoracotomywas performed at the 2nd intercostal
space, and the thorax was opened without exteriorization of the heart
(Tavares et al., 2010). The left anterior descending coronary artery
was identiﬁed and occluded with a 6-0 mononylon suture underneath
the left atrial appendage. Next, the thoracic cavity was closed with a
5-0 mononylon thread, the muscles were repositioned, and the skin
was sutured. The sham group was also submitted to a thoracotomy
without ligation of the coronary artery. All of the animals received anal-
gesia immediately after the surgical procedure (bupivacaine 1 mg/kg
was administered intramuscularly around the incision).
Troponin I measurements
Heparinized blood samples (1 mL) were drawn by retro-orbital
plexus puncture 2 and 8 h after surgery under isoﬂurane anesthesia.
The animals received subcutaneous saline volume replacement after
blood collection. The samples were immediately centrifuged at
1000 ×g for 10 min, and the plasma was stored at −80 °C. The cTnI
concentration was evaluated in an automated standard method
using an electrochemiluminescence immunoassay (ADVIA Centaur
CP, TnI-Ultra™, Siemens Healthcare Diagnostics Inc., Tarrytown, NY,
USA). This ultra-sensitive method is able to detect cTnI values rangingFig. 1. Timeline of the experimental design. The animals were allocated to either the
sham (n = 11) or the MI group (n = 40) and were followed over time. cTnI — blood
sampling for cTnI measurement. Echo — echocardiography under anesthesia.between 0.006 and 50 ng/mL and presents cross-reactivity with rat
cTnI, as previously demonstrated (O'Brien et al., 2006).
Echocardiography
Transthoracic echocardiography was performed 48 h and 14 days
after the MI using Philips Medical EnVisor HD System (Andover, MA,
USA) with a 12–13 MHz transducer (2 cm depth with fundamental
and harmonic imaging). Imaging at earlier times could not be
performed due to technical difﬁculties, such as acoustic barriers gen-
erated by the surgery. Animals were placed in the left lateral
decubitus position (45° angle) on a heat plate (37 °C) to obtain
cardiac images under sedation (ketamine 100 mg/kg and xylazine
10 mg/kg, intraperitoneal injection). The images were captured by
an operator who was blinded to the study groups, as previously de-
scribed (Tavares et al., 2010).
Left ventricular (LV) diastolic and systolic transverse areas (cm2)
were obtained by tracing the endocardial border at three levels: the
basal (at the tip of the mitral valve leaﬂets), middle (at papillary mus-
cle level), and apical (distal from the papillary muscle but before the
ﬁnal curve cavity) levels. Diastolic and systolic diameters (cm) were
measured using the M-Mode in the three previously described planes.
The ﬁnal value for each animal was obtained by taking the average of
all three planes. On each echocardiographic transverse plane (basal,
middle and apical) the arch corresponding to the segments with the
infarction (regions or segments of the myocardium showing one of
the following changes in myocardial kinetics: systolic movement
akinesis and/or a hypokinesis region — AHR) and the total endocardi-
al perimeter (EP) were measured at end-diastole. Infarction size (IS)
was estimated as % IS = (AHR/EP) × 100 (dos Santos et al., 2008;
Peron et al., 2006). The left ventricular ejection fraction was calculat-
ed as (end-diastolic volume − end-systolic volume / end-diastolic
volume) × 100; end-diastolic and end-systolic cavity volumes were
calculated using Simpson's rule (Mercier et al., 1982). Left ventricular
fractional shortening (LVFS) values were obtained using the following
equation: LVFS = diastolic diameter − systolic diameter / diastolic
diameter × 100 (Moises et al., 2000).
Heart harvesting and histopathological measurements
After 14 days, the animals were anesthetized (ketamine 100 mg/kg
and xylazine 10 mg/kg) and euthanized. The hearts were removed,
dissected quickly in a cold saline solution, formalin ﬁxed and parafﬁn
embedded. At this time, the remodeling process is considered to be
stable, with no further left ventricular wall thinning or alteration in
the MI volume (Fishbein et al., 1978).
Histopathological studies were performed using Sirius red staining.
Sections were photographed using Q Capture Pro Software v. 5.1.1.14
(Q Imaging Co. Burnaby, BC, Canada). For each area of the heart (the
basal, medial, and apical), ﬁve partial photos were obtained (at
10-fold magniﬁcation) to construct a whole image of the heart section
using Adobe Photoshop CS2 v.9.0 software (Adobe Systems Incorporat-
ed, CA, USA). The red staining area indicates the infarcted zone, and the
green staining area indicates the healthy zone. A pixel value was
obtained for each zone, and the ratio of the infarcted zone pixel to the
total pixel indicates the percentage of infarction. The values represent
the mean value among the basal, medial, and apical areas.
Statistical analyses
Quantitative analyses were performed using the Software Package
for Statistical Science (SPSS) (SPSS for Windows; Version 16, SPSS
Inc.; Chicago, IL). Variable distribution was assessed using the Sha-
piro–Wilk test, and a Spearman correlation was applied for correlation
analysis. Mean comparisons were made using a t-test or ANOVA
followed by a Tukey post-hoc analysis for data with a normal
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when asymmetric distribution was detected. Receiver operator charac-
teristic (ROC) curves were constructed to determine the signiﬁcant cut-
offs for the diagnosis of MI, using the histological assessment as
reference method. The sensitivity, speciﬁcity, positive predictive value,
and negative predictive value were also determined. Differences with
a p value of ≤0.05 were considered to be statistically signiﬁcant.Results
Plasma cTnI levels and histological analysis
Plasma cTnI levels increased in theMI group as early as 2 h after the
surgery (sham: 2.3 ± 1.0 ng/mL; MI: 7.2 ± 9.4 ng/mL; p b 0.01), with
a marked increase 8 h after MI (sham: 1.5 ± 1.7 ng/mL; MI: 22.2 ±
13.5 ng/mL; p b 0.001), as shown in Fig. 2. Histopathological analysis,
as a reference method for MI diagnosis, was performed 14 days after
MI (Fig. 3) and revealed an average ﬁbrosis area of 16.5 ± 8.8%.Echocardiographic analyses
As determined by echocardiography imaging, the infarction sizes
were 27.5 ± 16.7% and 25.4 ± 16.9% at 48 h and 14 days after MI, re-
spectively. Additional echocardiographic data are shown in Table 1.Correlation between plasma cTnI levels and infarction size
Plasma cTnI levels, measured 8 h post-MI, correlated with echo-
cardiographic measurements of infarction size at 14 days after MI
(r = 0.56, p b 0.001) (Fig. 4A). Additionally, plasma cTnI levels
were well correlated to the histological measurements of the infarc-
tion area (r = 0.74, p b 0.001) (Fig. 4B). Cardiac troponin levels
assessed 2 h after MI were not correlated to either echocardiographic
(r = 0.20, p = 0.32) or histological (r = 0.28, p = 0.09) estimates
of infarction size.Correlation between infarction size assessed by echocardiography and
histology
There was a strong positive correlation among echocardiography
evaluations 48 h and 14 days post-MI with histological measure-
ments (r = 0.84, p b 0.001 and r = 0.84, p b 0.001; respectively)
(Fig. 5A and B).Fig. 2. Plasma cTnI levels 2 and 8 h after myocardial infarction induction. Heparinized
blood was collected from the retro-orbital plexus 2 and 8 h after MI, and cTnI levels
were assessed in the sham group (n = 11 and 11, for 2 and 8 h, respectively) and in
the MI (n = 28 and 35, for 2 and 8 h, respectively) animals. Boxes represent the
interquartile range, horizontal bars represent median, and the whiskers represent
the 10–90th percentiles. The medians were compared using a Mann–Whitney test.Prediction of infarct size
To clarify whether plasma cTnI values at 8 h and echocardiographic
imaging at 48 h post-MI were useful in discriminating small, medium
and large MI, histology values obtained 14 days after MI were divided
into tertiles and plotted against cTnI levels (Fig. 6A) or echocardio-
graphic values (Fig. 6B and C). Plasma cTnI levels did not predict infarc-
tion area (Fig. 6A). However, echocardiographic measurements of the
infarction area 48 h and 14 days after the MI were well correlated
with infarction extension, as can be observed in Fig. 6B and C, and
may constitute a useful tool to discriminate small and medium/large
infarctions.
Diagnostic value of cTnI at 8 h post-MI
An ROC curve analysis was performed with cTnI levels at 8 h
post-MI to determine the best predictive cutoff value for the occur-
rence of myocardial infarction, diagnosed by histological analysis
14 days after the surgery (Fig. 7). We found that plasma cTnI levels
higher than 4.8 ng/mL predicted infarction with a sensitivity of
91.2% and speciﬁcity of 100% (Fig. 7). Additionally, this cutoff yielded
a positive predictive value of 100% and a negative predictive value of
78.5%.
Discussion
The main goal of this study was to assess plasma cTnI levels and
echocardiographic imaging as early tools to detect MI and estimate
infarction area in Wistar rats. These methodologies have already
been employed in animal research. However, in this study we present
original data demonstrating that cTnI levels and echocardiographic
imaging may be employed as early as 8 and 48 h after MI, respective-
ly. We observed that cTnI levels at as early as 8 h post-MI, can conﬁ-
dently diagnose infarct occurrence in a rat model of MI. Moreover,
echocardiographic data obtained at both 48 h and 14 days post-
procedure could distinguish small from medium/large areas as
assessed by histology at 14 days post-MI. To our knowledge, the
present study adds novel information regarding early identiﬁcation
of experimental infarction, as well as prediction of infarction size.
Rats and mice are widely used as preclinical models of MI and left
ventricular remodeling. A major pitfall of this model is the variability
of infarct size, which ranges from 8 to 65% (Degabriele et al., 2004).
This variability severely limits the model, and the results of early in-
terventions may not be accurately determined. These problems are
especially important in studies on infarction healing that usually de-
liver the treatment immediately after coronary occlusion (Le Visage
et al., 2012; Shyu et al., 2002). The generation of heterogeneous
groups may severely compromise the reliability of the results. Thus,
early assessment of MI size is pivotal and should be employed to i) re-
liably diagnose MI, ii) distribute the animals according to MI size into
treatment groups, and iii) provide information on the infarction size
to allow follow up on anti-remodeling therapies.
Troponin is the preferred biomarker for the detection of myocardi-
al necrosis and is a class I indication for the clinical diagnosis of MI
(Daubert and Jeremias, 2010; Jaffe et al., 2000; Morrow et al., 2007;
Thygesen et al., 2007). The methodology is simple and low cost and
excludes operator bias. Several studies have demonstrated that tropo-
nin concentrations in plasma from patients with acute coronary syn-
dromes correlate with the presence, complexity, and severity of
epicardial coronary artery disease, as well as with decreased myocar-
dial perfusion (Wilson et al., 2009; Wong et al., 2002). In animal
models, plasma biomarkers of cardiac injury have been employed to
estimate infarction size. Accordingly, Metzler et al. evaluated plas-
matic cTnT levels 24 h after MI and observed a positive correlation
with infarction size using triphenyltetrazolium chloride (r = 0.84)
(Metzler et al., 2002). Additionally, Jiang et al. assessed cTnT levels
BA
LV LVSP SPAWAW RV RV
Fig. 3. Sirius red histology 14 days post-myocardial infarction. Illustrative photomicrograph of an apical region from a healthy (A) and an infarcted heart (B). Green staining indi-
cates healthy myocardium, whereas red staining indicates ﬁbrosis. Red line = LV infarcted region; black line = LV health tissue. AW = anterior wall; LV = left ventricle; SP =
septum; RV = right ventricle.
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5 weeks post-MI (r = 0.87) (Jiang et al., 2011).
In the present study, we demonstrated that cTnI plasmatic levels
consistently increased 8 h after MI. Moreover, the plasma levels of
cTnI correlated with histopathological infarction size 14 days after
MI. Of note, cTnI has an advantage over cTnT because it is more
cardio-speciﬁc (Daubert and Jeremias, 2010).
Using ROC curve analysis, we also demonstrated that cTnI levels
higher than 4.8 ng/mL 8 h after MI provide a reliable cutoff value
for the diagnosis of MI in this rat model. The high positive predictive
value (100%) for the chosen cutoff is suitable for excluding individ-
uals with defective myocardial infarction, allowing for more homoge-
neous groups. Despite this great advantage, cTnI measured 8 h after
MI or earlier does not seem to be a useful tool in predicting infarct
size. This ﬁnding is in accordance with the modest association
between plasma cTnT levels measured earlier than 12 h post-
admission and infarct size measured 10 days after the onset of symp-
toms by SPECT-MPI, in patients with MI (Arruda-Olson et al., 2011).
Thus echocardiographic imaging was also evaluated in the present
study.
Echocardiographic imaging has been used to evaluate infarct size
in animals. In the ﬁrst hours after MI induction, scar tissue and myo-
cardial hibernation/stunning may interfere with measurements and
lead to overestimation of infarction size, respectively (Pierard et al.,
1990). Thus, images acquired very early post-MI may be misleading.
Nevertheless, few studies have employed this methodology to predict
infarction size. Santos et al. demonstrated that echocardiographic
measurement may accurately estimate infarction size 7 days after in-
farction induction (dos Santos et al., 2008). Our study veriﬁed that
echocardiographic measurements at an earlier time point (48 hTable 1
Cardiac function in rats 48 h and 14 days post surgery.
48 h 14 days
Sham MI Sham MI
N 8 31 8 32
Infarct area, % 0 27.5 ± 16.7 0 25.4 ± 16.9
LV ejection fraction, % 80.3 ± 3.2 54.2 ± 15.3a 73.8 ± 6.3 45.6 ± 18.7b
LV fractional shortening, % 51.9 ± 5.4 26.5 ± 11.7a 53.1 ± 8.4 24.8 ± 13.6b
Values expressed mean ± SD. LV = left ventricular.
a Signiﬁcantly different from sham at 48 h post-MI (Mann–Whitney test, p b 0.001).
b Signiﬁcantly different from sham at 14 days post-MI (Mann–Whitney test,
p b 0.001).post-MI) might accurately estimate infarction size by histology at
14 days post-MI. Therefore, echocardiography may be an important
tool to evaluate and estimate infarct size in a timely manner in animal
experiments.Fig. 4. Correlation between plasma cTnI levels and infarction area. A — cTnI levels vs.
echocardiographic infarct size at 14 days after MI (sham, n = 8; MI, n = 27); B —
cTnI levels vs. histology infarct size at 14 days after MI (sham, n = 11; MI, n = 35).
Δ, sham; Ο, myocardial infarction. ‘r’ indicates Spearman's correlation coefﬁcient.
Fig. 5. Correlation between echocardiography and histology. A — Relationship between
echocardiographic measurements at 48 h and mean histology infarct size at 14 days after
MI (sham, n = 8; MI, n = 31); B — Relationship between echocardiographic measure-
ments at 14 days and mean histology infarct size at 14 days after MI (sham, n = 8; MI,
n = 32). Δ, sham; Ο, myocardial infarction. ‘r’ indicates Spearman's correlation coefﬁcient.
Fig. 6. Histologic infarction size related to cTnI and echocardiographic data. A — Rela-
tionship between histologic infarct size and plasma cTnI levels 8 h post-MI (n = 12,
12, and 11, respectively). B— Relationship between histologic infarct size and echocar-
diographic measurements 48 h post-MI (n = 11, 11, and 9, respectively). C — Rela-
tionship between histologic infarct size and echocardiographic measurements
14 days post-MI (n = 12, 11, and 9, respectively). ANOVA followed by a Tukey test
was used in B, whereas a Kruskal–Wallis test was used in C and D. *p b 0.01.
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48 h after MI are as follows. First, since akinetic areas obtained by im-
aging correlated well with the infarct area determined by histology,
the echocardiographic results can predict infarct size at an early
stage. Thus, any variation in this predicted area could be safely attrib-
uted to the experimental treatment. Second, since echocardiographic
imaging was demonstrated to discriminate between small and medi-
um/large infarctions, it can be used to study the remodeling process
in a more detailed manner. Previous studies have clearly shown that
infarction sizes smaller than 16–20% have a different pattern of re-
modeling (Minicucci et al., 2011; Pfeffer and Braunwald, 1990).
Accordingly, animals showing such small infarct areas ought to be
excluded from studies exploring interventional strategies to halt or
modulate remodeling progression (Minicucci et al., 2011).
Our data should be viewed considering some limitations. First, de-
spite being performed by a skilled and blinded operator, the echocar-
diographic analysis was carried out by a single observer. Second,
blood was collected 8 h after MI, which is when cTnI is released at a
rapid pace (Lavin et al., 1995). A previous attempt to correlate tropo-
nin I levels with infarct size (estimated by late gadolinium hyper-
enhancement/cardiac magnetic resonance) found more scattered
sampling values at 12 h after patient admission than at 24 h
(Younger et al., 2007). Thus, despite rigorous control, small variations
in the time of collection at this phase may contribute to dispersed
troponin values to some degree. Finally, the assessment of cTnI levels
and echocardiography presented here is only valid in the MI modelusing rats without pre-existing conditions, such as diabetes, hyper-
tension or previous ischemic events. Because these conditions may
enhance cardiac remodeling, the times and values presented here
cannot be fully translated into clinical practice.
Conclusion
In conclusion, we found that a cutoff value for cTnI of 4.8 ng/mL at
8 h post-MI could be used to accurately identify Wistar rats with MI
Fig. 7. Receiver operating characteristic (ROC) curve for the prediction of MI by histol-
ogy according to cTnI levels at 8 h post-MI. Analysis of the sensitivity and speciﬁcity of
cTnI at 8 h to predict infarct size at 14 days post-MI (area under the curve = 0.989,
p b 0.001, n = 45). MI = myocardial infarction.
144 G.G. Vietta et al. / Life Sciences 93 (2013) 139–144using a fast, inexpensive, and readily available assay. Moreover, echo-
cardiographic images taken 48 h after MI may predict infarcted areas
14 days later. Taken together, our data may help to quickly select an-
imals that may be kept in an experimental protocol, achieving more
homogenous infarct groups and therefore substantially reducing the
sample sizes necessary to demonstrate treatment effects while im-
proving the power of trials addressing anti-remodeling therapies.
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